Dr. Linda A. DiMeglio works in clinical research with a focus on Type 1 diabetes prevention, beta cell preservation, and new technologies and therapeutics. She is a center director and chairs the publications committee for the TrialNet network and is the PI of the Immune Tolerance Network T1DES study. She has been the medical director of the American Diabetes Association Camp John Warvel since 1998.
DiMeglio is director of career development and co-chair of the Pediatric Protocol Development Team at the Indiana University Clinical and Translational Science Institute. She also is an active clinician; she sees patients with diabetes and endocrine disorders in clinic and teaches medical students, residents, house staff and fellows.
She serves on the editorial board for Diabetes Care and is a current ISPAD Advisory Council member and a member of the ISPAD Guidelines Editorial Board.
Areas of Expertise
Pediatric endocrinology, Type 1 diabetes, diabetes prevention, Type 1 diabetes research, epidemiology of diabetes.